Home  >  Products  >  SUCLA2 (succinate-CoA ligase, ADP-forming, beta subunit ) Blocking Peptide (the C terminal of SUCLA2)(100ug)
SUCLA2 (succinate-CoA ligase, ADP-forming, beta subunit ) Blocking Peptide (the C terminal of SUCLA2)(100ug)

SUCLA2 (succinate-CoA ligase, ADP-forming, beta subunit ) Blocking Peptide (the C terminal of SUCLA2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SUCLA2 Antibody (ARP64675_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64675
Size: 100ug
Weight: 45kDa
Gene: 8803
Format: Lyophilized powder
Target: Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6.
Alternative names: A-BETA; SCS-betaA
See Full Product Listings >